Delivery Order SPE2DB24D1104-SPE2DB25FYFB8
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $8,026.53 to AmerisourceBergen Drug Corp for the supply of Promacta 50 mg tablets in quantities of 30 units. This non-competitive, firm fixed price delivery order was awarded on August 18, 2025, with an ultimate completion date of September 9, 2025. The pharmaceutical products will be delivered to the place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $8,026.53 to AmerisourceBergen Drug Corp for the supply of Promacta 50 mg tablets in quantities of 30 units. This firm fixed-price delivery order, issued on August 5, 2025, with an ultimate completion date of August 26, 2025, represents a non-competitive award under the company's existing indefinite delivery contract (IDC) with DLA. The product will be supplied to the place of performance in Conshohocken, Pennsylvania, where...
- The Defense Logistics Agency awarded a delivery order valued at $8,026.53 to AmerisourceBergen Drug Corp for the supply of Promacta 50 mg tablets (30-tablet units) on July 22, 2025, with an ultimate completion date of August 12, 2025. This firm fixed-price delivery order, executed without a set-aside designation, was competitively awarded and represents a transaction under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (designated SPE2DX). The contract...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 5, 2025, for the supply of Promacta 50 mg tablets (30-count units) under a firm fixed-price contract with a ceiling value of $16,053.06 and an ultimate completion date of August 26, 2025. This non-set-aside award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999.99 billion prime vendor agreement valued through December...
- The Defense Logistics Agency awarded a $17,672.24 delivery order to AmerisourceBergen Drug Corp for Promacta 25 mg tablets (30-unit package) on July 22, 2025, with an ultimate completion date of August 12, 2025. This firm fixed-price delivery order is not set-aside and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The work will be performed at the contractor's...
- The Defense Logistics Agency awarded a $48,118.52 delivery order to AmerisourceBergen Drug Corp for the supply of Promacta 75 mg tablets (30-count units) with an ultimate completion date of August 14, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and is being performed at the contractor's location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical...
- The Defense Logistics Agency (DLA) Troop Support Medical has awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The $7,242.58 contract is for the supply of PROMACTA 50 MG TABLET UU 30S and has a completion date of March 18, 2024. Amerisourcebergen Drug Corp, as the prime contractor, will provide these pharmaceutical products from its corporate office located in...
- The Defense Logistics Agency awarded a delivery order valued at $12,029.63 to AmerisourceBergen Drug Corp for the supply of Promacta 75 mg tablets (30-unit packages) on August 21, 2025, with an ultimate completion date of September 12, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's...
- The Defense Logistics Agency awarded a $4,418.06 firm fixed-price delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Promacta 25 mg tablets (30-count units). The contract, which is a child delivery order under a larger indefinite delivery vehicle, carries an ultimate completion date of August 18, 2025, and will be performed at the company's corporate office location in Conshohocken, Pennsylvania. This award was made through open competition with no set-aside...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $8,026.53 on August 27, 2025, for the supply of Promacta 50 mg tablets (30-count units). This competitively awarded, firm fixed price contract represents a child order under AmerisourceBergen's broader Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion pharmaceutical supply vehicle running through December 2026. The delivery order is set to be completed by September...
- SPE2DB24D1104Indefinite Delivery Contract
- SPE2DB24D1104-SPE2DB25FYFB8Delivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $8,026.53 to AmerisourceBergen Drug Corp for the supply of Promacta 50 mg tablets (30-count units) on August 28, 2025, with completion scheduled for September 19, 2025. The contract employs firm fixed pricing and was awarded on a competitive, non-set-aside basis. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform this work at its corporate office location. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical designated SPE2DX, which carries a total value of $999,999,999.00 through December 2026. AmerisourceBergen Drug Corp serves as a major pharmaceutical distributor and critical vendor for federal medical procurement, supplying a comprehensive range of pharmaceutical products and medical supplies to military and veteran healthcare systems. The parent SPE2DX contract functions as a global pharmaceutical support vehicle enabling the company to supply specialty medications, brand-name and generic drugs, vaccines, and related medical commodities across multiple therapeutic domains to the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. AmerisourceBergen's demonstrated capability to fulfill federal medical supply requirements through competitive procurement, combined with its extensive portfolio of pharmaceutical product deliveries, positions the company as a significant supplier within the DLA's Medical Supply Chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $8.0k | 8/28/25 |